Abstract
AbstractIn Duchenne muscular dystrophy, dystrophin loss leads to chronic muscle damage, dysregulation of repair, fibro-fatty replacement, and weakness. We develop methodology to efficiently isolate individual nuclei from frozen skeletal muscle, allowing single nuclei sequencing of irreplaceable archival samples from small samples. We apply this method to identify cell and gene expression dynamics within human DMD and mdx mouse muscle, characterizing treatment effects of dystrophin rescue by exon skipping therapy at single nuclei resolution. DMD exon 23 skipping events are directly observed and increased in myonuclei from treated mice. We describe partial rescue of type IIa and IIx myofibers, expansion of a novel MDSC-like myeloid population, recovery of repair/remodeling M2-macrophage, and repression of inflammatory POSTN1+ fibroblasts in response to exon skipping and partial dystrophin restoration. Use of this method enables exploration of cellular and transcriptomic mechanisms of dystrophin loss and repair.
Publisher
Cold Spring Harbor Laboratory
Reference64 articles.
1. Immune-mediated pathology in Duchenne muscular dystrophy;Sci Transl Med,2015
2. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial;JAMA Neurol,2020
3. Developments in reading frame restoring therapy approaches for Duchenne muscular dystrophy;Expert Opin Biol Ther,2021
4. Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse;Mol Ther Nucleic Acids,2018
5. F. Chemello , A. C. Chai , H. Li , C. Rodriguez-Caycedo , E. Sanchez-Ortiz , A. Atmanli , A. A. Mireault , N. Liu , R. Bassel-Duby , E. N. Olson , Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing. Sci Adv 7, (2021).